Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography–Tandem Mass Spectrometry Method-Reference-Cited by-同舟云学术

Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography–Tandem Mass Spectrometry Method

Published:2011-08 Issue:4 Volume:33 Page:453-459
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Johnson-Davis Kamisha L,De Soumo,Jimenez Ernest,McMillin Gwendolyn A,De Barun K

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Exploring treatment options in renal transplantation: the problems of chronic allograft dysfunction and drug-related nephrotoxicity.;Campistol;Transplant,2001

2. Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy.;Pilmore;Clin Transplant,2002

3. Reduced exposure to calcineurin inhibitors in renal transplantation.;Ekberg;N Engl J Med,2007

4. Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.;Conti;Transplant Immunol,2008

5. Kidney transplantation without calcineurin inhibitors using sirolimus.;Stegall;Transplant Proc,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical techniques used in therapeutic drug monitoring;Therapeutic Drug Monitoring;2024

2. Evaluation of a batched-extraction method for measurement of sirolimus, tacrolimus, and cyclosporine on the Architect i2000SR;Clinica Chimica Acta;2022-06

3. Rapid determination of tacrolimus and sirolimus in whole human blood by direct coupling of solid-phase microextraction to mass spectrometry via microfluidic open interface;Analytica Chimica Acta;2021-02

4. Recent advances in electrogenerated chemiluminescence biosensing methods for pharmaceuticals;Journal of Pharmaceutical Analysis;2019-02

5. Issues of interferences in therapeutic drug monitoring;Accurate Results in the Clinical Laboratory;2019